MedTrace Logo

Oral Cancer Adjuvant Therapy (OCAT) Trial

NCT00193843 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2005-12-26

No results posted yet for this study

Summary

To demonstrate whether addition of Concurrent chemotherapy to post-operative adjuvant radiotherapy OR shortening of duration of post-operative radiotherapy, by administering 6 fractions / week instead of 5 fractions / week improves local-regional control and / or overall survival in high risk, locally advanced, resectable, squamous cell carcinoma of oral cavity.

Conditions

  • Mouth Neoplasms

Interventions

PROCEDURE

Post-operative chemoradiotherapy / accelerated radiotherapy

Sponsors & Collaborators

  • Tata Memorial Hospital

    lead OTHER_GOV

Principal Investigators

  • Mandar S Deshpande, MBBS,MS,DNB · Tata Memorial Hospital, Parel, Mumbai 12, Maharashtra, India

  • Mandar S Deshpande, MBBS,MS,DNB · Tata Memorial Hospital, Parel, Mumbai 12 .Maharshtra, India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2017-06-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00193843 on ClinicalTrials.gov